CCAP
Crescent Capital BDC, Inc.
CCAP trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over CCAP overall, supported by stronger fundamentals and stronger valuation.
CCAP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
CCAP's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCAP.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CCAP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.8x | $6.07 | -40% |
| Forward | 7x | $10.10 | — |
| Fair | 7.4x | $7.78 | -23% |
| Expensive | 9.4x | $9.89 | -2.1% |
| Current | 9.7x | $10.10 | — |
Historical ranges are pointers, not guarantees.
CCAP's PE is in its expensive range at 9.7x. On analysts' estimates for next year's earnings, today's price would be 7.0x, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CCAP in the historical PE scenario, which offers more potential upside but is not a forecast.
CCAP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect CCAP's earnings and revenue to decline, with profitability weakening.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CCAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.45 | +38% |
| Q3 2026 | $1.05 | -45% |
| Q2 2026 | $1.23 | -41% |
| Q1 2026 | $1.78 | -20% |
| Q4 2025 | $1.81 | -25% |
| Q3 2025 | $1.91 | -23% |
| Q2 2025 | $2.09 | -14% |
| Q1 2025 | $2.22 | -7.1% |
| Q4 2024 | $2.40 | +4.3% |
CCAP's earnings per share have fallen from their peak: $1.05 over the past year, against $5.34 in early 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CCAP on earnings, with more consistent year-over-year improvement.
CCAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $6.6M | -82% |
| Q1 2022 | $23M | -3.1% |
| Q4 2021 | $18.7M | -49% |
| Q3 2021 | $22.9M | -43% |
| Q2 2021 | $35.8M | -38% |
| Q4 2020 | $36.5M | +220% |
JPM has the stronger quarterly revenue trend. Revenue is down 82% for CCAP versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -9.2% | -104 points |
| Q1 2022 | 71% | -21 points |
| Q4 2021 | 77% | -18 points |
| Q3 2021 | 75% | -21 points |
| Q2 2021 | 95% | -3.4 points |
| Q1 2021 | 92% | N/A |
| Q4 2020 | 96% | +16 points |
| Q3 2020 | 97% | N/A |
CCAP's operating margin was −9.2% last quarter, down 104 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
CCAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.4M | -21% |
| Q2 2026 | $9.8M | -73% |
| Q1 2026 | -$23.8M | -$8.7M |
| Q4 2025 | $22.6M | +$25.5M |
| Q3 2025 | $30.8M | -34% |
| Q2 2025 | $36.4M | +$61.1M |
| Q1 2025 | -$15.1M | -138% |
| Q4 2024 | -$2.9M | -108% |
CCAP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CCAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -8.5K shares |
| 1 year | -0.6% | -215K shares |
| 3 years | -0.6% | -216K shares |
| 5 years | +31% | +8.7M shares |
| Available history | +41% | +10.6M shares |
CCAP has 37M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $667,000 |
| Q1 2026 | $1M |
| Q4 2025 | $1M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
CCAP spent $3M buying back its own shares over the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CCAP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CCAP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 13.4x | High |
| Q1 2022 | 7.6x | High |
| Q4 2021 | 7.1x | High |
| Q3 2021 | 5.1x | High |
| Q2 2021 | 3.8x | Elevated |
| Q1 2021 | 3.2x | Elevated |
| Q4 2020 | 8.5x | High |
| Q3 2020 | 14.2x | High |
CCAP's net debt is about 13 years of its operating earnings (EBITDA), up from 3.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CCAP.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CCAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 34.5 | Neutral |
CCAP's weekly RSI is 45 (neutral) and its Stochastic is 35 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CCAP PE vs Financial Services Sector
| Metric | CCAP | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 85 | 65 | 20 pts above |
CCAP has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CCAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.25 | 9.2% above |
| 20 week MA | $10.2 | 0.6% below |
| 50 week MA | $12.0 | 15% below |
| 100 week MA | $14.0 | 28% below |
| 200 week MA | $15.4 | 34% below |
CCAP has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 34% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over CCAP on trend strength, trading above more of its moving averages.
CCAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.1 | $15.0 | -12% |
| 2021 | $15.0 | $18.0 | +20% |
| 2022 | $18.0 | $13.1 | -27% |
| 2023 | $13.1 | $17.4 | +32% |
| 2024 | $17.4 | $19.8 | +14% |
| 2025 | $19.8 | $14.7 | -25% |
| 2026 YTD | $14.7 | $10.1 | -31% |
CCAP has finished lower in three of the last six years. It's down 31% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over CCAP on returns for 2026, with the stronger performance.